arrow
E

Eric D. Hsi

washington university
H指数:87
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Venetoclax added to dose-adjusted EPOCH-R for newly diagnosed double-hit lymphomas: phase 2 results from ALLIANCE A051701, an open-label, randomised, controlled, phase 2-3 trial

维奈克拉联合剂量调整的EPOCH-R方案治疗新诊断的双打击淋巴瘤:来自ALLIANCE A051701开放标签、随机对照、II-III期试验的II期结果

2026-08-010
PRE
Application of Hi-C sequencing to detect oncogene rearrangements for diagnosis and treatment of large B-cell lymphoma

Hi-C测序在大型B细胞淋巴瘤的诊断和治疗中检测癌基因重排的应用

2026-06-170
OAAI
Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis

活体巨噬细胞和DLBCL细胞中促炎性GSDMD的激活标志着配体相互作用和更好的预后

2025-12-080
OAAI
Prognostic effects and immune biomarkers associated with gasdermin protein expression in diffuse large B-cell lymphoma
2025-11-010
PRE
Clinical Validation of Duoseq, a novel assay for clinical DNA and RNA sequencing

Duoseq的临床验证,一种用于临床DNA和RNA测序的新型检测方法

2025-10-280
PRE
Acute Leukemias of Ambiguous Lineage With RUNX1 Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With RUNX1 Mutations: A Study From the Bone Marrow Pathology Group

具有RUNX1突变的模糊系急性白血病与具有RUNX1突变的急性髓系白血病相比,预后相似:一项来自骨髓病理学组的研究

2025-10-180
PRE
Convolutional neural network-derived neurofibrillary tangle classifiers: Investigative tools to identify maturation levels and explore post-translational modifications using laser capture microdissection coupled mass spectrometry

卷积神经网络衍生的神经原纤维缠结分类器:用于识别成熟水平并探索翻译后修饰的激光捕获显微切割耦合质谱研究工具

2025-09-010
PRE
Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma

预后基因表达和微RNA表达谱特征以及原发性睾丸弥漫性大B细胞淋巴瘤的遗传改变

2025-07-170
PREAI
Acute Leukemias of Ambiguous Lineage With MDS-Associated Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With MDS-Associated Mutations: A Study From the Bone Marrow Pathology Group
2024-11-230
PRE
Trial in Progress- Alliance A052101: A Randomized Phase 3 Trial of Continuous Vs. Intermittent Maintenance Therapy with Zanubrutinib As Upfront Treatment in Older Patients with Mantle Cell Lymphoma

试验进行中-联盟A052101:一项关于在老年套细胞淋巴瘤患者中,作为一线治疗使用zanubrutinib进行持续与间歇维持治疗的随机III期试验

BLOOD
IF23.1
2024-11-050
PRE
DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphoma

DNA错配修复缺陷与肿瘤内异质性缺陷以不同方式影响弥漫大B细胞淋巴瘤中的免疫应答

2024-08-050
OA